IRIS
DENTONE, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.789
Totale 5.789
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 5.789
Totale 5.789
Salva come PNG Salva come JPEG
Città #
Genova 3.095
Rapallo 1.049
Genoa 1.035
Vado Ligure 571
Bordighera 39
Totale 5.789
Salva come PNG Salva come JPEG
Nome #
The Ligurian Human Immunodeficiency Virus Clinical Network: A Web Tool to Manage Patients With Human Immunodeficiency Virus in Primary Care and Multicenter Clinical Trials 186
Effectiveness, safety, durability and immune recovery in a retrospective, multicentre, observational cohort of ART-experienced, HIV-1-infected patients receiving maraviroc 172
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 166
A Web based tool for antimicrobial resistance evaluation in immunocompromised patient 152
Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: A multicenter regional simulation 151
A Standard Interface for Data Reuse in Infectious Diseases 144
Budget Impact Analysis of Sofosbuvir-Based Regimens for The Treatment of Hiv/Hcv Co-Infected Patients In Northern Italy: The Liguria Region Simulation 141
Multicentre Clinical Trials’ data management: A hybrid solution to exploit the strengths of Electronic Data Capture and Electronic Health Records systems 136
Inpatient admissions of patients living with HIV in two European centres (UK and Italy); comparisons and contrasts 127
Use of colistin in adult patients: a cross-sectional study 126
Use of maraviroc in clinical practice: a multicenter observational study 124
A comparison of inpatient admissions in 2012 from two European countries 124
Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA < 50 cp/mL 124
Rete Ligure dell’HIV: due anni di esperienza nella gestione del dato clinico 114
Cost per care of the first year of direct antiviral agents in the liguria region: A multicenter analysis 113
Web interaction to improve collaboration in monitoring of microbial infections 109
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 109
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 106
From Liguria HIV Web to Liguria Infectious Diseases Network: How a Digital Platform Improved Doctors' Work and Patients' Care 100
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 98
Weight gain: A possible side effect of all antiretrovirals 90
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 88
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 87
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 86
Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance 86
LiHlm-Web: a web-application in order to collect, share and analyze immunological data of HIV patients in multicentric studies 85
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 85
Bloodstream infections in critically ill patients with COVID-19 84
CD8+CD28-CD127loCD39+ T reg: a new biomarker for HIV infection 83
Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals 81
Valutazione di parametri di immunità innata e di infiammazione correlati ad aspetti clinico-metabolici in una coorte di pazienti HIV positivi con carica virale non rilevabile 80
Control of the HIV-1 DNA reservoir is associated in vivo and in vitro with NKp46/NKp30 (CD335 CD337) inducibility and interferon gamma production by transcriptionally unique NK cells 79
Ricoveri ospedalieri dei pazienti con infezione da HIV in Liguria: risultati preliminari dello studio ACTEA 77
Utilizzo di Maraviroc nella pratica clinica: studio multicentrico osservazionale (MARHIV STUDY) 76
Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients 71
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 70
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors 68
Assessment of appropriateness of first-line combined antiretroviral treatment (cART): the preliminary results of Liguria experience V.E.L.A. study 67
Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients 67
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 66
Lipid profile improvement in virologically suppressed hiv-1-infected patients switched to dolutegravir/ abacavir/lamivudine: Data from the SCOLTA project 63
CD8+CD28-CD127loCD39+Treg Expansion: a New Pathogenic Mechanism for HIV Infection? 62
Una rete multicentrica standardizzata per gestire e analizzare le co-morbidità e gli effetti collaterali legati a terapie HAART in pazienti con infezione da HIV 60
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 60
The Ligurian HIV network: How medical informatics standards can help clinical research 58
Use of ceftaroline in hospitalized patients with and without covid-19: A descriptive cross-sectional study 58
Early effects of ventilatory rescue therapies on systemic and cerebral oxygenation in mechanically ventilated COVID-19 patients with acute respiratory distress syndrome: a prospective observational study 55
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 55
Lung distribution of gas and blood volume in critically ill COVID-19 patients: a quantitative dual-energy computed tomography study 54
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 53
The impact of liver disease: a leading cause of hospital admissions in people living vith HIV 52
Immunological profile of an infant treated with integrase inhibitor from the neonatal period 51
A very rare case of mycobacterium gordonae infection of the breast 50
Spread of carbapenem-resistant gram-negatives and candida auris during the covid-19 pandemic in critically ill patients: One step back in antimicrobial stewardship? 48
Characterization of T lymphocytes in severe COVID-19 patients 48
Early administration of bamlanivimab in combination with etesevimab increases the benefits of covid-19 treatment: Real-world experience from the liguria region 48
A comparative analysis of the first and second COVID-19 wave in Italy: evaluation of mortality in the Infectious Disease Unit of Genoa University Hospital 47
Clinical efficacy of eucaloric ketogenic nutrition in the COVID-19 cytokine storm: A retrospective analysis of mortality and intensive care unit admission 46
High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection 45
Higher mortality and intensive care unit admissions in COVID-19 patients with liver enzyme elevations 42
Enterococcal bloodstream infections in critically ill patients with COVID-19: a case series 38
Reactivation of Herpes Simplex Virus Type 1 (HSV-1) Detected on Bronchoalveolar Lavage Fluid (BALF) Samples in Critically Ill COVID-19 Patients Undergoing Invasive Mechanical Ventilation: Preliminary Results from Two Italian Centers 38
Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting? 35
Is a step-down antiretroviral therapy necessary to fight severe acute respiratory syndrome coronavirus 2 in HIV-infected patients? 35
HCMV-controlling NKG2C+ NK cells originate from novel circulating inflammatory precursors 34
High prevalence of olfactory and taste disorder during SARS-CoV-2 infection in outpatients 34
Clinical significance of inflammatory markers of bacterial infection in critically ill patients with COVID-19 after treatment with anti-inflammatory and immunomodulatory drugs: A complex new scenario 33
Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients 32
High-temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines 30
The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient-A Case Study 27
Effect of SARS-CoV-2 vaccination in a vulnerable COVID-19 cohort: a real-life experience in an Italian Hospital 26
Triple combination therapy with two antivirals and monoclonal antibodies for persistent or relapsed SARS-CoV-2 infection in immunocompromised patients 26
Prevalence of Viral Hepatitis in Unselected, Consecutively Enrolled Patients Hospitalised for SARS-CoV-2 25
Early Clinical Experience with Molnupiravir for Mild to Moderate Breakthrough COVID-19 among Fully Vaccinated Patients at Risk for Disease Progression 25
Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 Vaccination 25
Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders 25
Factors Associated With Weight Gain in People Treated With Dolutegravir 25
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 24
Behind the screens: Clinical decision support methodologies - A review 23
Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care 23
Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study 23
Ten Years of Medical Informatics and Standards Support for Clinical Research in an Infectious Diseases Network 20
Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring 20
Early and Polyantigenic CD4 T Cell Responses Correlate with Mild Disease in Acute COVID-19 Donors 18
T2Bacteria and T2Resistance Assays in Critically Ill Patients with Sepsis or Septic Shock: A Descriptive Experience 18
On-field evaluation of a ultra-rapid fluorescence immunoassay as a frontline test for SARS-CoV-2 diagnostic 17
Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19 15
Distinct features of immune activation and exhaustion markers in people with perinatally-acquired HIV 7
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 6
Neutralizing monoclonal antibodies for the prevention of severe COVID-19: a retrospective study during Omicron BA.1 variant surge 4
Triple antiviral treatment for COVID-19 in an immunocompromised patient 2
Totale 5.986
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.377
article - articoli 23.070
book - libri 0
conference - conferenze 3.104
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 203
Totale 52.754
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020914 0 0 0 0 86 137 171 82 112 181 115 30
2020/2021547 21 39 52 54 42 56 43 49 44 61 36 50
2021/2022789 31 35 38 73 47 46 33 180 70 87 42 107
2022/20231.299 96 134 11 156 147 163 54 86 140 102 187 23
2023/2024832 43 82 16 106 80 171 50 53 34 33 62 102
2024/2025621 80 146 60 189 146 0 0 0 0 0 0 0
Totale 5.986